Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Healthtrust
Boehringer Ingelheim
US Department of Justice
Cipla
Baxter
Merck
Federal Trade Commission
Cantor Fitzgerald
McKesson

Generated: February 21, 2018

DrugPatentWatch Database Preview

CEFACLOR Drug Profile

« Back to Dashboard

Which patents cover Cefaclor, and when can generic versions of Cefaclor launch?

Cefaclor is a drug marketed by Ceph Intl, Dava Pharms Inc, Hikma, Ivax Sub Teva Pharms, Ranbaxy, Teva, Watson Labs Inc, Yung Shin Pharm, Facta Farma, and World Gen. and is included in twenty-nine NDAs.

The generic ingredient in CEFACLOR is cefaclor. There are thirteen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the cefaclor profile page.
Drug patent expirations by year for CEFACLOR
Pharmacology for CEFACLOR
Medical Subject Heading (MeSH) Categories for CEFACLOR

US Patents and Regulatory Information for CEFACLOR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Yung Shin Pharm CEFACLOR cefaclor FOR SUSPENSION;ORAL 065412-003 Feb 17, 2012 RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ranbaxy CEFACLOR cefaclor FOR SUSPENSION;ORAL 064165-001 Oct 2, 1997 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
World Gen CEFACLOR cefaclor TABLET, EXTENDED RELEASE;ORAL 065057-001 Jan 5, 2001 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ivax Sub Teva Pharms CEFACLOR cefaclor FOR SUSPENSION;ORAL 064086-001 Apr 28, 1995 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ranbaxy CEFACLOR cefaclor FOR SUSPENSION;ORAL 064164-001 Oct 2, 1997 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ivax Sub Teva Pharms CEFACLOR cefaclor FOR SUSPENSION;ORAL 064085-001 Apr 28, 1995 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ceph Intl CEFACLOR cefaclor CAPSULE;ORAL 062205-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Yung Shin Pharm CEFACLOR cefaclor CAPSULE;ORAL 065146-002 Jan 22, 2004 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Facta Farma CEFACLOR cefaclor FOR SUSPENSION;ORAL 062206-003 Apr 20, 1988 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Yung Shin Pharm CEFACLOR cefaclor FOR SUSPENSION;ORAL 065412-001 Feb 17, 2012 RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Mallinckrodt
Accenture
Citi
Colorcon
Cantor Fitzgerald
Johnson and Johnson
Argus Health
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot